Sequence information
Variant position: 263 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: 451 The length of the canonical sequence.
Location on the sequence:
RFDGALNVDLTEFQTNLVPY
P RIHFPLATYAPVISAEKAYH
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human RFDGALNVDLTEFQTNLVPYP RIHFPLATYAPVISAEKAYH
Chimpanzee RFDGALNVDLTEFQTNLVPYP RIHFPLATYAPVISAEKAYH
Mouse RFDGALNVDLTEFQTNLVPYP RIHFPLATYAPVISAEKAYH
Rat RFDGALNVDLTEFQTNLVPYP RIHFPLATYAPVISAEKAYH
Pig RFDGALNVDLTEFQTNLVPYP RAHFPLATYAPVISAEKAYH
Sequence annotation in neighborhood: The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:Type: the type of sequence feature. Positions: endpoints of the sequence feature. Description: contains additional information about the feature.
Type Positions Description
Chain
1 – 451
Tubulin alpha-1A chain
Chain
1 – 450
Detyrosinated tubulin alpha-1A chain
Active site
254 – 254
Modified residue
282 – 282
3'-nitrotyrosine
Literature citations
Large spectrum of lissencephaly and pachygyria phenotypes resulting from de novo missense mutations in tubulin alpha 1A (TUBA1A).
Poirier K.; Keays D.A.; Francis F.; Saillour Y.; Bahi N.; Manouvrier S.; Fallet-Bianco C.; Pasquier L.; Toutain A.; Tuy F.P.; Bienvenu T.; Joriot S.; Odent S.; Ville D.; Desguerre I.; Goldenberg A.; Moutard M.L.; Fryns J.-P.; van Esch H.; Harvey R.J.; Siebold C.; Flint J.; Beldjord C.; Chelly J.;
Hum. Mutat. 28:1055-1064(2007)
Cited for: TISSUE SPECIFICITY; VARIANTS LIS3 LEU-188; THR-263; CYS-264; PHE-286; HIS-402; CYS-402 AND LEU-419;
Disclaimer:
Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.